Calidi Biotherapeutics (CLDI) EPS (Basic) (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly EPS (Basic) of -$942.82 for Q4 2025, down 15250.57% year-over-year from N/an in Q4 2024, and up 57.25% quarter-over-quarter from -$2205.4 in Q3 2025.
Calidi Biotherapeutics (CLDI) EPS (Basic) (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$942.82 for Q4 2025.
- In Q4 2025, EPS (Basic) fell 15250.57% year-over-year to -$942.82; the TTM figure through Dec 2025 stood at -$5945.8 (down 16554.97% YoY), while the FY2025 annual figure was -$5945.8, down 16554.97% from the prior year.
- EPS (Basic) for Q4 2025 stood at -$942.82, up from -$2205.4 in the prior quarter.
- The five-year high for EPS (Basic) was $21.71 in Q2 2022, with the low at -$2209.1 in Q1 2025.
- The 4-year median for EPS (Basic) is -$41.82 (2022), against an average of -$495.27.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 93.58% in 2024, then slumped 28350.28% in 2025.
- Calidi Biotherapeutics' EPS (Basic) stood at -$52.66 in 2022, then dropped by 11.05% to -$58.48 in 2023, then jumped by 89.5% to -$6.14 in 2024, then plunged by 15250.57% to -$942.82 in 2025.
- Business Quant data shows CLDI's EPS (Basic) at -$942.82 in Q4 2025, -$2205.4 in Q3 2025, and -$1986.4 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.18 |
| 10 | Calidi Biotherapeutics | 1.97 Mn | -2.13 Mn | - | -2.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.94 |
| Dec 31, 2025 | -942.82 |
| Sep 30, 2025 | -2,205.42 |
| Jun 30, 2025 | -1,986.44 |
| Mar 31, 2025 | -2,209.13 |
| Dec 31, 2024 | -6.14 |
| Sep 30, 2024 | -7.75 |
| Jun 30, 2024 | -16.75 |
| Mar 31, 2024 | -24.39 |
| Dec 31, 2023 | -58.48 |
| Sep 30, 2023 | -16.97 |
| Jun 30, 2023 | -260.90 |
| Mar 31, 2023 | -134.86 |
| Dec 31, 2022 | -52.66 |
| Sep 30, 2022 | -30.98 |
| Jun 30, 2022 | 21.71 |
| Mar 31, 2022 | 7.63 |